Showing results (1-10 of 873) with videos related to
Sort By:
Pageof 88
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 3, 2014
Pharmacogenetics of antipsychoticsEva J Brandl, James L Kennedy, Daniel J MüllerPharmacogenomics|August 2, 2014
Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for cliniciansGwyneth Zai, Eva J Brandl, Daniel J Müller, et al.Psychiatry Research|April 28, 2018
Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medicationLucas M Walden, Eva J Brandl, Arun K Tiwari, et al.Pharmacogenomics|December 20, 2011
Pharmacogenetics of obsessive-compulsive disordersEva J Brandl, Daniel J Müller, Margaret A RichterPharmacogenomics|September 20, 2006
Genetics of antipsychotic treatment emergent weight gain in schizophreniaDaniel J Müller, James L KennedyJournal of Neural Transmission (Vienna, Austria : 1996)|August 25, 2014
Genetic variation in CYP3A43 is associated with response to antipsychotic medicationEva J Brandl, Nabilah I Chowdhury, Arun K Tiwari, et al.Current Pharmaceutical Design|June 12, 2012
Genetics and personalized medicine in antidepressant treatmentKatarina Gvozdic, Eva J Brandl, Danielle L Taylor, et al.Pharmacogenomics|March 15, 2014
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Nabilah I Chowdhury, et al.Human Psychopharmacology|February 1, 2013
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Tristram A Lett, et al.Psychiatry Research|June 24, 2014
No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gainEva J Brandl, Arun K Tiwari, Clement C Zai, et al.Pageof 88